PERTUZUMAB
pertuzumab 420 mg/14 mL injection, 14 mL vial
PERTUZUMAB (10334X)
10334X
Manner of administration:Injection
Restriction
Indication: Metastatic (Stage IV) HER2 positive breast cancer
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 840 mg | # of repeats: 0 | DPMA: $5,760.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Perjeta
(pertuzumab 420 mg/14 mL injection, 14 mL vial)
|
||||
